Literature DB >> 23575337

Tuberculosis is associated with increased lung cancer mortality.

C C Leung1, L Hui, R S Y Lee, T H Lam, W W Yew, D S C Hui, R C Y Chan, T Y W Mok, W S Law, K C Chang, E C C Leung, C M Tam.   

Abstract

SETTING: Elderly persons living in the community in Hong Kong.
OBJECTIVE: To examine the association between tuberculosis (TB) and lung cancer.
DESIGN: Elderly clients enrolled in a health programme from 2000 to 2003 were retrospectively cross-matched with the territory-wide TB notification registry for TB before enrolment. The cohort was followed up prospectively through linkage with the territory-wide death registry for cause of death until 31 December 2011. All subjects with suspected malignancy or recent weight loss (≥5%) at enrolment and deaths within the first 2 years of follow-up were excluded.
RESULTS: Of the 61,239 subjects included, 516 had TB before enrolment. After 490,258 person-years of follow-up, respectively 1344, 910 and 2003 deaths were caused by lung cancer, other tobacco-related malignancies and non-tobacco-related malignancies. TB before enrolment was associated with death due to lung cancer (Mantel-Haenszel weighted relative risk 2.61, 95%CI 1.82-3.74, P < 0.001) but not other malignancies after stratification by sex. TB remained an independent predictor of lung cancer death (adjusted hazard ratio 2.01, 95%CI 1.40-2.90; P < 0.001), after adjustment for multiple potential confounders.
CONCLUSIONS: TB was independently associated with subsequent mortality due to lung cancer. This finding calls for intensification of tobacco control and better targeting of lung cancer screening in high TB burden areas.

Entities:  

Mesh:

Year:  2013        PMID: 23575337     DOI: 10.5588/ijtld.12.0816

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  11 in total

1.  Cohort Profile: Hong Kong Department of Health Elderly Health Service Cohort.

Authors:  C M Schooling; W M Chan; S L Leung; T H Lam; S Y Lee; C Shen; J Y Leung; G M Leung
Journal:  Int J Epidemiol       Date:  2014-12-05       Impact factor: 7.196

2.  Efficacy and safety of concurrent anti-tuberculosis treatment and chemotherapy in lung cancer patients with co-existent tuberculosis.

Authors:  Mei-Feng Ye; Shan Su; Zhi-Hao Huang; Jian-Jun Zou; Duo-Hua Su; Xiao-Hui Chen; Long-Feng Zeng; Wei-Xiang Liao; Hui-Yi Huang; Yun-Yun Zeng; Wen-Chang Cen; Xian-Lan Zhang; Chun-Xin Liao; Jian Zhang; Yan-Bin Zhang
Journal:  Ann Transl Med       Date:  2020-09

3.  The Impact of Coexisting Asthma, Chronic Obstructive Pulmonary Disease and Tuberculosis on Survival in Patients with Lung Squamous Cell Carcinoma.

Authors:  Jing-Yang Huang; Zhi-Hong Jian; Oswald Ndi Nfor; Kai-Ming Jhang; Wen-Yuan Ku; Pei-Chieh Ko; Shiou-Rung Jan; Chien-Chang Ho; Chia-Chi Lung; Hui-Hsien Pan; Yu-Chiu Liang; Yung-Po Liaw
Journal:  PLoS One       Date:  2015-07-21       Impact factor: 3.240

4.  Pre-existing Pulmonary Diseases and Survival in Patients With Stage-dependent Lung Adenocarcinoma: A STROBE-compliant Article.

Authors:  Zhi-Hong Jian; Jing-Yang Huang; Oswald Ndi Nfor; Kai-Ming Jhang; Wen-Yuan Ku; Chien-Chang Ho; Chia-Chi Lung; Hui-Hsien Pan; Yu-Chiu Liang; Ming-Fang Wu; Yung-Po Liaw
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

5.  Impact of coexisting pulmonary diseases on survival of patients with lung adenocarcinoma: a STROBE-compliant article.

Authors:  Zhi-Hong Jian; Jing-Yang Huang; Pei-Chieh Ko; Shiou-Rung Jan; Oswald Ndi Nfor; Chia-Chi Lung; Wen-Yuan Ku; Chien-Chang Ho; Hui-Hsien Pan; Yung-Po Liaw
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

6.  The coexistence of common pulmonary diseases on the histologic type of lung cancer in both genders in Taiwan: a STROBE-compliant article.

Authors:  Zhi-Hong Jian; Chia-Chi Lung; Jing-Yang Huang; Pei-Chieh Ko; Shiou-Rung Jan; Oswald Ndi Nfor; Wen-Yuan Ku; Chien-Chang Ho; Hui-Hsien Pan; Yung-Po Liaw
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

7.  The safety and efficacy of immunotherapy with anti-programmed cell death 1 monoclonal antibody for lung cancer complicated with Mycobacterium tuberculosis infection.

Authors:  Jinpeng Shi; Jiayu Li; Qi Wang; Xiaomin Cheng; He Du; Ruoshuang Han; Xuefei Li; Chao Zhao; Guanghui Gao; Yayi He; Xiaoxia Chen; Chunxia Su; Shengxiang Ren; Fengying Wu; Zhemin Zhang; Caicun Zhou
Journal:  Transl Lung Cancer Res       Date:  2021-10

8.  An Integrative Network Approach to Identify Common Genes for the Therapeutics in Tuberculosis and Its Overlapping Non-Communicable Diseases.

Authors:  Aftab Alam; Hala Abubaker Bagabir; Armiya Sultan; Mohd Faizan Siddiqui; Nikhat Imam; Mustfa F Alkhanani; Ahmad Alsulimani; Shafiul Haque; Romana Ishrat
Journal:  Front Pharmacol       Date:  2022-01-27       Impact factor: 5.810

Review 9.  The Common miRNAs between Tuberculosis and Non-Small Cell Lung Cancer: A Critical Review.

Authors:  Mojgan Sheikhpour; Hanie Abolfathi; Morteza Karimipoor; Abolfazl Movafagh; Mahbubeh Shahsavani
Journal:  Tanaffos       Date:  2021-03

Review 10.  Comparison of clinical and imaging features between pulmonary tuberculosis complicated with lung cancer and simple pulmonary tuberculosis: a systematic review and meta-analysis.

Authors:  Weiguo Sun; Lingxia Zhang; Jianqin Liang; Xianan Li; Yimei Yang; Wenna Sun; Jianghou Hou
Journal:  Epidemiol Infect       Date:  2022-02-02       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.